Smith, Moore & Co’s BlackRock Science and Technology Term Trust BSTZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-182,909
Closed -$3.42M 398
2023
Q1
$3.42M Sell
182,909
-5,276
-3% -$92.6K 0.46% 40
2022
Q4
$2.94M Buy
188,185
+3,534
+2% +$60.1K 0.41% 47
2022
Q3
$3.26M Buy
184,651
+18,615
+11% +$383K 0.49% 34
2022
Q2
$3.25M Buy
166,036
+35,988
+28% +$844K 0.5% 36
2022
Q1
$3.82M Buy
130,048
+15,172
+13% +$453K 0.52% 37
2021
Q4
$4.47M Buy
114,876
+26,629
+30% +$1.06M 0.62% 27
2021
Q3
$3.4M Buy
88,247
+25,372
+40% +$1.03M 0.52% 35
2021
Q2
$2.62M Buy
62,875
+6,331
+11% +$240K 0.4% 52
2021
Q1
$2.02M Buy
56,544
+2,541
+5% +$92.6K 0.33% 66
2020
Q4
$1.97M Sell
54,003
-10,434
-16% -$322K 0.37% 58
2020
Q3
$1.65M Buy
+64,437
New +$1.61M 0.34% 62

Other funds holding BSTZ

Smith, Moore & Co's BSTZ Position: Q2 2023 in Review

Smith, Moore & Co sold out of BlackRock Science and Technology Term Trust (BSTZ) in Q2 2023, closing a stake of 182,909 shares — an estimated $3.42M sold.

Smith, Moore & Co first reported a position in BSTZ in Q3 2020 and held it in 11 quarters. The position peaked at $4.47M in Q4 2021. 90 funds tracked by Wall St. Rank hold BSTZ as of Q2 2023.

  • Smith, Moore & Co reported no remaining BlackRock Science and Technology Term Trust position as of Q2 2023 after selling out during the quarter.
  • Smith, Moore & Co sold 182,909 BlackRock Science and Technology Term Trust shares in Q2 2023, an estimated $3.42M.
  • Smith, Moore & Co first reported a position in BlackRock Science and Technology Term Trust in Q3 2020 and held it in 11 quarters.
  • Smith, Moore & Co's BlackRock Science and Technology Term Trust position peaked at $4.47M in Q4 2021.
  • 90 funds tracked by Wall St. Rank held BlackRock Science and Technology Term Trust as of Q2 2023.

Based on Smith, Moore & Co's 13F filing for Q2 2023, filed 11 Aug 2023.